WILMINGTON, N.C. & WINSTON-SALEM, N.C., July 11, 2012 /PRNewswire/ -- Inclinix-PMG Holdings, a global clinical trial site and patient recruitment organization, today announced changes to the executive management team.
Dr. John Rubino of Raleigh Medical Group (RMG) has been appointed Medical Director of Inclinix-PMG Holdings, Inc. and also will serve as the head of the Principal Investigator Advisory Board. Dr. Rubino has been actively involved in clinical research for the past 22 years, and has been a Principal Investigator in over 600 trials. He was instrumental in developing clinical research in association with RMG and will lend his experience and expertise in clinical research to the Inclinix-PMG Holdings organization. Dr. Rubino says, "I look forward to helping meld the strengths of both Inclinix and PMG into the premier research organization by focusing on making our research efforts a win for patients, physicians and our research sponsors."
Jennifer Byrne has been named President and Chief Operating Officer of PMG Research Inc. Ms. Byrne has 25 years experience in the clinical research field. Through her various management roles, she has been influential in guiding the development and growth of PMG Research for the past 20 years, and will continue to do so in this capacity.
Denise Robinson has been named President and Chief Operating Officer of Inclinix, Inc. Ms. Robinson has over 15 years of pharmaceutical, clinical and healthcare experience. She has served in multiple leadership roles with Inclinix in her 10-year tenure and her experience and insight will provide valuable strategic direction for Inclinix.
"Together Inclinix and PMG Research bring forth an unrivaled precedent for research site-based experience which will allow for better outcomes for pharmaceutical sponsors, physician investigators, and research participants," says Ms. Byrne. Denise Robinson explains, "This merger is the great outcome of years of successf
|SOURCE Inclinix-PMG Holdings, Inc.|
Copyright©2012 PR Newswire.
All rights reserved